Inventor · disambiguated record
Vaniambadi Kalyanaraman
Also filed as: KALYANARAMAN VANIAMBADI · KALYANARAMAN VANIAMBADI S
7 granted patents·2 pending applications·76 citations·filing 1989–2012
85Inventor score
Files withAKZO NOBEL NV3AKZO NV2UNIV MASSACHUSETTS2ADVANCED BIOSCIENCE LAB INC1KALYANARAMAN VANIAMBADI1
Top patents by PatentIndex Score
9 records- 0188US7901690B2Polyvalent, primary HIV-1 glycoprotein DNA vaccines and vaccination methodsUNIV MASSACHUSETTS·Filed 2003·Granted Mar 8, 2011·33 cites·34 claims
- 0269US5766844AHuman T-cell line infected with HIV-2 which secretes functionally intact HIV-2 GP160.AKZO NOBEL NV·Filed 1996·Granted Jun 16, 1998·21 cites·3 claims
- 0353US10081658B2Truncated HIV envelope proteins (ENV), methods and compositions related theretoKALYANARAMAN VANIAMBADI·Filed 2012·Granted Sep 25, 2018·1 cites·25 claims
- 0452US2005220816A1Mutant viral nucleic acids and vaccine containing sameADVANCED BIOSCIENCE LAB INC·Filed 2004·Application pending·0 cites
- 0546US5122468AHut-78 cell lines infected with HTLV-III which secrete gp160AKZO NV·Filed 1989·Granted Jun 16, 1992·7 cites·3 claims
- 0645US2011171258A1Polyvalent, primary hiv-1 glycoprotein dna vaccines and vaccination methodsUNIV MASSACHUSETTS·Filed 2011·Application pending·0 cites
- 0743US5116740AMethod for producing native hiv gp160AKZO NV·Filed 1989·Granted May 26, 1992·9 cites·2 claims
- 0842US5736317AHuman T-cell line infected with HIV-2 which secretes a protein corresponding to native HIV-2 gp160 in an extracellular mediumAKZO NOBEL NV·Filed 1995·Granted Apr 7, 1998·4 cites·5 claims
- 0933US5876732AHuman T-cell line infected with HIV-2 which secretes functionally intact HIV-2 GP160AKZO NOBEL NV·Filed 1998·Granted Mar 2, 1999·1 cites·5 claims
Join the waitlist — get patent alerts
Get an alert when Vaniambadi Kalyanaraman files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →